Evidence map›Paper›PMID 23879608›Full record

ReviewExpert review of anti-infective therapy2013

Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection.

Wanessa C M A de Melo, Pinar Avci, Milene Nóbrega de Oliveira, Asheesh Gupta, Daniela Vecchio, Magesh Sadasivam, Rakkiyappan Chandran, Ying-Ying Huang, Rui Yin, Livia R Perussi and 4 more

Abstract readReview
In one paragraph

Review in Expert review of anti-infective therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Assessment of photodynamic therapy efficacy againstJournal of biomedical optics · 2025
    Article
  14. Article
  15. Diseases (Basel, Switzerland) · 2024
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wanessa C M A de MeloThe Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Pinar Avci
Milene Nóbrega de Oliveira
Asheesh Gupta
Daniela Vecchio
Magesh Sadasivam
Rakkiyappan Chandran
Ying-Ying Huang
Rui Yin
Livia R Perussi
George P Tegos
Janice R Perussi
Tianhong Dai
Michael R Hamblin

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
NIAID NIH HHS R01 AI050875
6 · The paper itself

Abstract

Microbial biofilms are responsible for a variety of microbial infections in different parts of the body, such as urinary tract infections, catheter infections, middle-ear infections, gingivitis, caries, periodontitis, orthopedic implants, and so on. The microbial biofilm cells have properties and gene expression patterns distinct from planktonic cells, including phenotypic variations in enzymic activity, cell wall composition and surface structure, which increase the resistance to antibiotics and other antimicrobial treatments. There is consequently an urgent need for new approaches to attack biofilm-associated microorganisms, and antimicrobial photodynamic therapy (aPDT) may be a promising candidate. aPDT involves the combination of a nontoxic dye and low-intensity visible light which, in the presence of oxygen, produces cytotoxic reactive oxygen species. It has been demonstrated that many biofilms are susceptible to aPDT, particularly in dental disease. This review will focus on aspects of aPDT that are designed to increase efficiency against biofilms modalities to enhance penetration of photosensitizer into biofilm, and a combination of aPDT with biofilm-disrupting agents.

Indexed as

Drug Resistance, MicrobialPhotochemotherapyBacterial InfectionsBiofilmsCombined Modality TherapyHumansMicrobial Sensitivity TestsMycosesReactive Oxygen SpeciesTetrapyrrolesReactive Oxygen SpeciesTetrapyrroles

Identifiers

PMID23879608
PMCPMC4336791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.